{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:46:21Z","timestamp":1792583181544,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.modpat.2026.101059","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:01:02Z","timestamp":1785996062000},"page":"101059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Long, Remarkable History of KRAS and Pancreatic Cancer: From Gene Discovery to Successful Therapeutic Targeting"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4554-5672","authenticated-orcid":false,"given":"Ralph H.","family":"Hruban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5507","key":"10.1016\/j.modpat.2026.101059_bib2","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The sequence of the human genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science"},{"issue":"6822","key":"10.1016\/j.modpat.2026.101059_bib3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.79.2.137","article-title":"Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III","volume":"79","author":"Avery","year":"1944","journal-title":"J Exp Med"},{"issue":"4922","key":"10.1016\/j.modpat.2026.101059_bib4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.modpat.2026.101059_bib5","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib6","first-page":"311","article-title":"Morphologic responses to a murine erythroblastosis virus","volume":"39","author":"Kirsten","year":"1967","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.modpat.2026.101059_bib7","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa2505783","article-title":"Daraxonrasib in previously treated advanced RAS-mutated pancreatic cancer","volume":"394","author":"Wolpin","year":"2026","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib8","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.modpat.2026.101059_bib9","series-title":"Two drugs stir hope for treatment of deadly pancreatic cancer","author":"Robbins","year":"2026"},{"issue":"6","key":"10.1016\/j.modpat.2026.101059_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"5547","key":"10.1016\/j.modpat.2026.101059_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/260170a0","article-title":"DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA","volume":"260","author":"Stehelin","year":"1976","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.modpat.2026.101059_bib12","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1073\/pnas.79.11.3637","article-title":"Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses","volume":"79","author":"Der","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5892","key":"10.1016\/j.modpat.2026.101059_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/300539a0","article-title":"Oncogenes in solid human tumours","volume":"300","author":"Pulciani","year":"1982","journal-title":"Nature"},{"issue":"4563","key":"10.1016\/j.modpat.2026.101059_bib14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.6287573","article-title":"Nucleotide sequence of the oncogene encoding the p21 transforming protein of Kirsten murine sarcoma virus","volume":"217","author":"Tsuchida","year":"1982","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.modpat.2026.101059_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191939","article-title":"KRAS: the Achilles' heel of pancreas cancer biology","volume":"135","author":"Drizyte-Miller","year":"2025","journal-title":"J Clin Invest"},{"issue":"18","key":"10.1016\/j.modpat.2026.101059_bib16","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1056\/NEJMe2600517","article-title":"Advances in RAS therapeutics for pancreatic cancer","volume":"394","author":"Der","year":"2026","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41392-025-02473-8","article-title":"Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges","volume":"10","author":"Choucair","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"1-3","key":"10.1016\/j.modpat.2026.101059_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/hsz-2025-0244","article-title":"The heart of the matter: a personal view of Fred Wittinghofer's contributions to RAS biology and drug design","volume":"407","author":"McCormick","year":"2026","journal-title":"Biol Chem"},{"issue":"4637","key":"10.1016\/j.modpat.2026.101059_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.6695174","article-title":"Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient","volume":"223","author":"Santos","year":"1984","journal-title":"Science"},{"issue":"6120","key":"10.1016\/j.modpat.2026.101059_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/327293a0","article-title":"Prevalence of ras gene mutations in human colorectal cancers","volume":"327","author":"Bos","year":"1987","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/bjc.1989.14","article-title":"Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer","volume":"59","author":"Slebos","year":"1989","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0006-291X(85)80140-6","article-title":"Activation of the c-K-ras oncogene in a human pancreas carcinoma","volume":"127","author":"Hirai","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.modpat.2026.101059_bib23","first-page":"792","article-title":"Activation of c-Ki-ras gene in human pancreatic cancer","volume":"76","author":"Prassolov","year":"1985","journal-title":"Jpn J Cancer Res"},{"issue":"4","key":"10.1016\/j.modpat.2026.101059_bib24","first-page":"370","article-title":"Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes","volume":"77","author":"Yamada","year":"1986","journal-title":"Jpn J Cancer Res"},{"issue":"4","key":"10.1016\/j.modpat.2026.101059_bib25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","article-title":"Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes","volume":"53","author":"Almoguera","year":"1988","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.modpat.2026.101059_bib26","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1093\/nar\/16.16.7773","article-title":"KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas","volume":"16","author":"Smit","year":"1988","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib27","first-page":"545","article-title":"K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization","volume":"143","author":"Hruban","year":"1993","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma","volume":"32","year":"2017","journal-title":"Cancer Cell"},{"issue":"5924","key":"10.1016\/j.modpat.2026.101059_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1171202","article-title":"Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene","volume":"324","author":"Jones","year":"2009","journal-title":"Science"},{"issue":"7592","key":"10.1016\/j.modpat.2026.101059_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"7424","key":"10.1016\/j.modpat.2026.101059_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.modpat.2026.101059_bib32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(19910201)67:3<634::AID-CNCR2820670318>3.0.CO;2-7","article-title":"Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases","volume":"67","author":"Tada","year":"1991","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2026.101059_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00189573","article-title":"Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients","volume":"425","author":"Sessa","year":"1994","journal-title":"Virchows Arch"},{"issue":"16","key":"10.1016\/j.modpat.2026.101059_bib34","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1158\/1078-0432.CCR-14-0513","article-title":"Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts","volume":"20","author":"Singhi","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"52","key":"10.1016\/j.modpat.2026.101059_bib35","doi-asserted-by":"crossref","first-page":"21188","DOI":"10.1073\/pnas.1118046108","article-title":"Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways","volume":"108","author":"Wu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"501","key":"10.1016\/j.modpat.2026.101059_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav4772","article-title":"A multimodality test to guide the management of patients with a pancreatic cyst","volume":"11","author":"Springer","year":"2019","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.modpat.2026.101059_bib37","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1245\/s10434-025-18848-8","article-title":"PancreaSeq genomic classifier (PancreaSeq GC) improves pancreatic cyst classification and detection of advanced neoplasia: a multi-institutional validation study","volume":"33","author":"Singhi","year":"2026","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101059_bib38","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1136\/gutjnl-2017-315062","article-title":"IPMNs with co-occurring invasive cancers: neighbours but not always relatives","volume":"67","author":"Felsenstein","year":"2018","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.modpat.2026.101059_bib39","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2019.06.001","article-title":"Intraductal papillary mucinous neoplasms arise from multiple independent clones, each with distinct mutations","volume":"157","author":"Fischer","year":"2019","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.modpat.2026.101059_bib40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jclinpath-2021-207598","article-title":"Molecular heterogeneity of pancreatic intraductal papillary mucinous neoplasms and implications for novel endoscopic tissue sampling strategies","volume":"75","author":"Rift","year":"2021","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101059_bib41","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/gutjnl-2020-321217","article-title":"Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions","volume":"70","author":"Fujikura","year":"2021","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPA.0000000000000253","article-title":"Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas","volume":"44","author":"Kuboki","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.modpat.2026.101059_bib43","series-title":"Tumors of the Pancreas","author":"Klimstra","year":"2023"},{"issue":"12","key":"10.1016\/j.modpat.2026.101059_bib44","first-page":"4923","article-title":"A white paper: the product of a pancreas cancer think tank","volume":"61","author":"Kern","year":"2001","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.modpat.2026.101059_bib45","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.pas.0000126675.59108.80","article-title":"An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms","volume":"28","author":"Hruban","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101059_bib46","first-page":"1547","article-title":"K-ras mutations in pancreatic ductal proliferative lesions","volume":"145","author":"Klimstra","year":"1994","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101059_bib47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02784932","article-title":"The role of Ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis","volume":"14","author":"Tabata","year":"1993","journal-title":"Int J Pancreatol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101059_bib48","first-page":"953","article-title":"Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation","volume":"53","author":"Yanagisawa","year":"1993","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.modpat.2026.101059_bib49","first-page":"889","article-title":"Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma","volume":"144","author":"DiGiuseppe","year":"1994","journal-title":"Am J Pathol"},{"issue":"13","key":"10.1016\/j.modpat.2026.101059_bib50","first-page":"3568","article-title":"Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia","volume":"54","author":"Caldas","year":"1994","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.modpat.2026.101059_bib51","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2011.12.042","article-title":"Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia","volume":"142","author":"Kanda","year":"2012","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.modpat.2026.101059_bib52","first-page":"2969","article-title":"Progression model for pancreatic cancer","volume":"6","author":"Hruban","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"8012","key":"10.1016\/j.modpat.2026.101059_bib53","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-024-07359-3","article-title":"3D genomic mapping reveals multifocality of human pancreatic precancers","volume":"629","author":"Braxton","year":"2024","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.modpat.2026.101059_bib54","first-page":"2140","article-title":"p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma","volume":"57","author":"Moskaluk","year":"1997","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.modpat.2026.101059_bib55","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)64432-X","article-title":"Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia","volume":"161","author":"van Heek","year":"2002","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1158\/0008-5472.CAN-05-2168","article-title":"Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations","volume":"66","author":"Hruban","year":"2006","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.modpat.2026.101059_bib57","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.modpat.2026.101059_bib58","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1101\/gad.1158703","article-title":"Activated Kras and Ink4a\/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma","volume":"17","author":"Aguirre","year":"2003","journal-title":"Genes Dev"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib59","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1172\/JCI59227","article-title":"Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice","volume":"122","author":"Collins","year":"2012","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.modpat.2026.101059_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049707","article-title":"Metastatic pancreatic cancer is dependent on oncogenic Kras in mice","volume":"7","author":"Collins","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.modpat.2026.101059_bib61","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1349-7006.1993.tb00185.x","article-title":"Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers","volume":"84","author":"Watanabe","year":"1993","journal-title":"Jpn J Cancer Res"},{"issue":"11","key":"10.1016\/j.modpat.2026.101059_bib62","first-page":"2472","article-title":"Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma","volume":"53","author":"Tada","year":"1993","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00006676-199601000-00003","article-title":"Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis","volume":"12","author":"Watanabe","year":"1996","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.modpat.2026.101059_bib64","doi-asserted-by":"crossref","first-page":"188","DOI":"10.7326\/0003-4819-123-3-199508010-00005","article-title":"Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer","volume":"123","author":"Berth\u00e9lemy","year":"1995","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<96::AID-CNCR11>3.0.CO;2-8","article-title":"K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma","volume":"82","author":"Wilentz","year":"1998","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2026.101059_bib66","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/1097-0142(19940315)73:6<1589::AID-CNCR2820730609>3.0.CO;2-7","article-title":"Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma","volume":"73","author":"Kondo","year":"1994","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.modpat.2026.101059_bib67","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cgh.2014.11.028","article-title":"KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound","volume":"13","author":"Eshleman","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101059_bib68","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/gutjnl-2015-311166","article-title":"Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms","volume":"66","author":"Yu","year":"2017","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.modpat.2026.101059_bib69","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1097\/SLA.0000000000005904","article-title":"A combined DNA\/RNA-based next-generation sequencing platform to improve the classification of pancreatic cysts and early detection of pancreatic cancer arising from pancreatic cysts","volume":"278","author":"Nikiforova","year":"2023","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.modpat.2026.101059_bib70","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2214\/AJR.07.3340","article-title":"Prevalence of unsuspected pancreatic cysts on MDCT","volume":"191","author":"Laffan","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101059_bib71","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/j.gastro.2015.07.041","article-title":"A combination of molecular markers and clinical features improve the classification of pancreatic cysts","volume":"149","author":"Springer","year":"2015","journal-title":"Gastroenterology"},{"issue":"224","key":"10.1016\/j.modpat.2026.101059_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"issue":"6378","key":"10.1016\/j.modpat.2026.101059_bib73","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib74","first-page":"271","article-title":"A prospective study of K-ras mutations in the plasma of pancreatic cancer patients","volume":"4","author":"Mulcahy","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.modpat.2026.101059_bib75","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jamasurg.2019.2832","article-title":"Screening for Pancreatic Cancer Gets a D, but the Student Is Improving","volume":"154","author":"Hruban","year":"2019","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.modpat.2026.101059_bib76","first-page":"1527","article-title":"Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features","volume":"4","author":"Yamada","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.modpat.2026.101059_bib77","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/annonc\/mdy417","article-title":"Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer","volume":"29","author":"Kruger","year":"2018","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101059_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.gassur.2026.102359","article-title":"Postsurgical circulating tumor DNA as a prognostic biomarker for relapse of resected pancreatic ductal adenocarcinoma","volume":"30","author":"Guo","year":"2026","journal-title":"J Gastrointest Surg"},{"issue":"22","key":"10.1016\/j.modpat.2026.101059_bib79","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1158\/1078-0432.CCR-25-0758","article-title":"The prognostic impact of early ctDNA kinetics in metastatic pancreatic cancer using the ctDNA-RECIST","volume":"31","author":"Steiniche","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib80","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s43018-023-00697-7","article-title":"The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients","volume":"5","author":"Osipov","year":"2024","journal-title":"Nat Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib81","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/1097-0142(19930715)72:2<432::AID-CNCR2820720219>3.0.CO;2-#","article-title":"K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung","volume":"72","author":"Westra","year":"1993","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.modpat.2026.101059_bib82","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1349-7006.1993.tb00184.x","article-title":"Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine","volume":"84","author":"Tsutsumi","year":"1993","journal-title":"Jpn J Cancer Res"},{"issue":"11","key":"10.1016\/j.modpat.2026.101059_bib83","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1349-7006.1993.tb02807.x","article-title":"K-ras gene mutation in early ductal lesions induced in a rapid production model for pancreatic carcinomas in Syrian hamsters","volume":"84","author":"Tsutsumi","year":"1993","journal-title":"Jpn J Cancer Res"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib84","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/carcin\/17.2.303","article-title":"High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters","volume":"17","author":"Sugio","year":"1996","journal-title":"Carcinogenesis"},{"issue":"2-3","key":"10.1016\/j.modpat.2026.101059_bib85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mrrev.2009.07.003","article-title":"Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes","volume":"682","author":"Porta","year":"2009","journal-title":"Mutat Res"},{"issue":"6561","key":"10.1016\/j.modpat.2026.101059_bib86","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj0486","article-title":"Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis","volume":"373","author":"Del Poggetto","year":"2021","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.modpat.2026.101059_bib87","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.05.011","article-title":"Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence","volume":"19","author":"Guerra","year":"2011","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.modpat.2026.101059_bib88","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ccr.2007.01.012","article-title":"Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice","volume":"11","author":"Guerra","year":"2007","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.modpat.2026.101059_bib89","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031542","article-title":"Genetically engineered mouse models of k-ras-driven lung and pancreatic tumors: validation of therapeutic targets","volume":"8","author":"Drosten","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib90","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41568-020-00325-x","article-title":"Tracing the origins of KRAS oncogene addiction","volume":"21","author":"O'Leary","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"32","key":"10.1016\/j.modpat.2026.101059_bib91","doi-asserted-by":"crossref","first-page":"15823","DOI":"10.1073\/pnas.1904529116","article-title":"Drugging an undruggable pocket on KRAS","volume":"116","author":"Kessler","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.modpat.2026.101059_bib92","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nrd4389","article-title":"Drugging the undruggable RAS: mission possible?","volume":"13","author":"Cox","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.modpat.2026.101059_bib93","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc.2017.36","article-title":"Drugging the 'undruggable' cancer targets","volume":"17","author":"Dang","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.modpat.2026.101059_bib94","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41589-024-01691-5","article-title":"Direct RAS inhibitors turn 10","volume":"20","author":"Ostrem","year":"2024","journal-title":"Nat Chem Biol"},{"issue":"18","key":"10.1016\/j.modpat.2026.101059_bib95","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1016\/S0021-9258(18)47433-9","article-title":"Preparation and characterization of nucleotide-free and metal ion-free p21 \u201capoprotein\u201d","volume":"262","author":"Feuerstein","year":"1987","journal-title":"J Biol Chem"},{"issue":"7477","key":"10.1016\/j.modpat.2026.101059_bib96","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib97","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/acs.jmedchem.9b01180","article-title":"Discovery of a covalent inhibitor of KRASG12C (AMG 510) for the treatment of solid tumors","volume":"63","author":"Lanman","year":"2020","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib98","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8290.CD-19-1167","article-title":"The KRASG12C inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients","volume":"10","author":"Hallin","year":"2020","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib99","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/2159-8290.CD-22-1066","article-title":"Efficacy of a small-molecule inhibitor of KrasG12D in immunocompetent models of pancreatic cancer","volume":"13","author":"Kemp","year":"2023","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.modpat.2026.101059_bib100","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/s41591-022-02007-7","article-title":"Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor","volume":"28","author":"Hallin","year":"2022","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.modpat.2026.101059_bib101","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","article-title":"Identification of MRTX1133, a noncovalent, potent, and selective KRASG12D inhibitor","volume":"65","author":"Wang","year":"2022","journal-title":"J Med Chem"},{"issue":"6659","key":"10.1016\/j.modpat.2026.101059_bib102","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.adg9652","article-title":"Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS","volume":"381","author":"Schulze","year":"2023","journal-title":"Science"},{"issue":"8013","key":"10.1016\/j.modpat.2026.101059_bib103","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41586-024-07205-6","article-title":"Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy","volume":"629","author":"Holderfield","year":"2024","journal-title":"Nature"},{"issue":"6758","key":"10.1016\/j.modpat.2026.101059_bib104","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads0239","article-title":"A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors","volume":"389","author":"Weller","year":"2025","journal-title":"Science"},{"issue":"8013","key":"10.1016\/j.modpat.2026.101059_bib105","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41586-024-07379-z","article-title":"Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer","volume":"629","author":"Wasko","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib106","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s42004-025-01662-4","article-title":"Discovery of KRAS(G12D) selective degrader ASP3082","volume":"8","author":"Yoshinari","year":"2025","journal-title":"Commun Chem"},{"issue":"14","key":"10.1016\/j.modpat.2026.101059_bib107","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMoa2600752","article-title":"Setidegrasib in advanced non-small-cell lung cancer and pancreatic cancer","volume":"394","author":"Park","year":"2026","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.modpat.2026.101059_bib108","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41417-026-01034-7","article-title":"Preclinical development of a mutant KRAS targeting therapeutic cancer vaccine","volume":"33","author":"Pinto","year":"2026","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib109","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/s41467-026-68324-4","article-title":"Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial","volume":"17","author":"Huff","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2026.101059_bib110","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-25-2245","article-title":"First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts","author":"Haldar","year":"2026","journal-title":"Cancer Discov. Preprint"},{"issue":"8","key":"10.1016\/j.modpat.2026.101059_bib111","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-25-0821","article-title":"KRAS inhibitors in pancreas cancer: facts and hopes about the immunotherapy we have all been waiting for","volume":"32","author":"Stanger","year":"2026","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.modpat.2026.101059_bib112","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.annonc.2026.01.011","article-title":"Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant trials (PATHdata): results of a Society for Immunotherapy of Cancer multi-institutional reproducibility study","volume":"37","author":"Deutsch","year":"2026","journal-title":"Ann Oncol"},{"issue":"25","key":"10.1016\/j.modpat.2026.101059_bib113","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1056\/NEJMoa2105281","article-title":"Acquired resistance to KRASG12C inhibition in cancer","volume":"384","author":"Awad","year":"2021","journal-title":"N Engl J Med"},{"issue":"7886","key":"10.1016\/j.modpat.2026.101059_bib114","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-021-04065-2","article-title":"Diverse alterations associated with resistance to KRAS(G12C) inhibition","volume":"599","author":"Zhao","year":"2021","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.modpat.2026.101059_bib115","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.cell.2026.03.031","article-title":"Disrupted molecular glue complex drives RAS inhibitor resistance","volume":"189","author":"Sang","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.modpat.2026.101059_bib116","doi-asserted-by":"crossref","first-page":"0030","DOI":"10.34133\/cancomm.0030","article-title":"Transcriptional and epigenetic plasticity drive an alternative non-clonal mechanism of resistance to KrasG12D inhibition in pancreatic cancer","volume":"46","author":"Caggiano","year":"2026","journal-title":"Cancer Commun (Lond)"},{"issue":"11","key":"10.1016\/j.modpat.2026.101059_bib117","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1158\/1078-0432.CCR-25-1788","article-title":"Overcoming adaptive resistance to KRASG12D blockade in pancreatic cancer through vertical pathway inhibition","volume":"32","author":"Lin","year":"2026","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.modpat.2026.101059_bib118","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.annonc.2025.01.020","article-title":"Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors","volume":"36","author":"Riedl","year":"2025","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib119","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.trecan.2024.11.009","article-title":"KRAS inhibitors: resistance drivers and combinatorial strategies","volume":"11","author":"Isermann","year":"2025","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2026.101059_bib120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10555-020-09953-z","article-title":"Pancreatic cancer pathology viewed in the light of evolution","volume":"40","author":"No\u00eb","year":"2021","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"10.1016\/j.modpat.2026.101059_bib121","doi-asserted-by":"crossref","first-page":"246","DOI":"10.7326\/0003-4819-148-3-200802050-00019","article-title":"Translation of genetic discoveries into clinical therapies","volume":"148","author":"Hackam","year":"2008","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.modpat.2026.101059_bib122","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrd4336","article-title":"The discovery of first-in-class drugs: origins and evolution","volume":"13","author":"Eder","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.modpat.2026.101059_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174538","article-title":"Modeling timelines for translational science in cancer; the impact of technological maturation","volume":"12","author":"McNamee","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib124","first-page":"12","article-title":"Innesto positivo con filtrato di verruca volgare","volume":"48","author":"Ciuffo","year":"1907","journal-title":"Giornale Ital Mal Venereol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101059_bib125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers\u2014a brief historical account","volume":"384","author":"zur Hausen","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.modpat.2026.101059_bib126","article-title":"Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity","volume":"51","author":"Zeitouni","year":"2025","journal-title":"Lancet Reg Health Am"},{"issue":"1678","key":"10.1016\/j.modpat.2026.101059_bib127","first-page":"51","article-title":"Tuberculosis in Dr Granville's mummy: a molecular re-examination of the earliest known Egyptian mummy to be scientifically examined and given a medical diagnosis","volume":"277","author":"Donoghue","year":"2010","journal-title":"Proc Biol Sci"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib128","first-page":"E9","article-title":"The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus","volume":"58","author":"Barberis","year":"2017","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"10.1016\/j.modpat.2026.101059_bib129","article-title":"Novel pharmacological approaches for multidrug-resistant tuberculosis: review","volume":"2025","author":"Ayenew","year":"2025","journal-title":"Adv Pharmacol Pharm Sci"},{"issue":"23","key":"10.1016\/j.modpat.2026.101059_bib134","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2610708123","article-title":"A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance","volume":"123","author":"Liaki","year":"2026","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.modpat.2026.101059_bib130","first-page":"1501","article-title":"Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+","volume":"152","author":"Goggins","year":"1998","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101059_bib131","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1053\/j.gastro.2019.10.028","article-title":"Recurrent rearrangements in PRKACA and PRKACB in intraductal oncocytic papillary neoplasms of the pancreas and bile duct","volume":"158","author":"Singhi","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.modpat.2026.101059_bib133","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.2164-0947.1980.tb02775.x","article-title":"Stigler\u2019s Law of Eponymy","volume":"39","author":"Stigler","year":"1980","journal-title":"Transactions of the New York Academy of Sciences"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522600102X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522600102X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:28:37Z","timestamp":1792582117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522600102X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":133,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S089339522600102X"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101059","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Long, Remarkable History of KRAS and Pancreatic Cancer: From Gene Discovery to Successful Therapeutic Targeting","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101059"}}